733
edits
No edit summary |
|||
Line 63: | Line 63: | ||
Clinical outcome after revascularization (predominantly for ACS) is similar for HIV-infected and non-infected populations, regardless of whether revascularization is performed percutaneously or surgically.<cite>55</cite><cite>56</cite> HIV-infected patients, however, do remain at increased risk for recurrent ACS during follow-up<cite>57</cite>, which is importantly associated with persistently elevated lipid spectra. | Clinical outcome after revascularization (predominantly for ACS) is similar for HIV-infected and non-infected populations, regardless of whether revascularization is performed percutaneously or surgically.<cite>55</cite><cite>56</cite> HIV-infected patients, however, do remain at increased risk for recurrent ACS during follow-up<cite>57</cite>, which is importantly associated with persistently elevated lipid spectra. | ||
==References== | ==References== |